It also covers generic medicines from Novartis' Sandoz unit that are used to treat heart failure and hypertension (amlodipine, bisoprolol, hydrochlorothiazide, furosemide and ramipril), high ...

A federal appeals court in the US has declined to overturn an attempt by Novartis to block the launch of a generic version of its blockbuster heart failure drug Entresto. The US Court of Appeals ...

with the lead indication for prevention of stroke and systemic embolism in patients with atrial fibrillationAcquisition adds a late-stage asset and is aligned with Novartis strategic focus ...

Job Title Sort ascending Business Location Site Date Posted Therapeutic Area Partner Regular (Sales), Full time Innovative Medicines Utd.Arab Emir. Dubai Feb 03, 2025 Senior Specialist, IT Information ...

The Delhi High Court on February 3 passed an interim injunction restraining a pharmaceutical company from using the trademark "NOVITAS" in response to a trademark infringement suit filed by global ...

Novartis India Ltd., incorporated in the year 1947, is a Small Cap company (having a market cap of Rs 2,146.62 Crore) operating in Pharmaceuticals sector. Novartis India Ltd. key Products/Revenue ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

According to iSpot.TV’s analysis of January TV drug ad spending data, Novartis’ prostate cancer drug Pluvicto swooped in to take the No. 1 spot on the list, with more than $47 million spent ...

The Company entered into a License Agreement with Novartis granting global rights ... Administration approval for anti-hypertension drug amlodipine besylate tablets in multiple strengths and ...